Impact of Systemic Anti-Her2 Treatment on Overall Survival in Patients With Brain Metastases From Her2-overexpressing Breast Cancer

被引：1
|
作者：
Bartsch, R. [1 ,2 ]
Berghoff, A. [1 ,2 ]
Pluschnig, U. [1 ,2 ]
Bago-Horvath, Z. [3 ]
Dubsky, P. [4 ]
Rottenfusser, A. [5 ]
Gnant, M.
Mader, R. [1 ,2 ,4 ]
Zielinski, C. C. [1 ,2 ]
Steger, G. G. [1 ,2 ]
机构：
[1] Med Univ Vienna, Dept Med 1, Vienna, Austria
[2] Med Univ Vienna, Ctr Canc, Vienna, Austria
[3] Med Univ Vienna, Dept Pathol, Vienna, Austria
[4] Med Univ Vienna, Dept Surg, Vienna, Austria
[5] Med Univ Vienna, Dept Radiotherapy, Vienna, Austria
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)71503-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S348 / S348
页数：1
相关论文
共 50 条
  • [31] Activity of fulvestrant in HER2-overexpressing advanced breast cancer
    Robertson, J. F. R.
    Steger, G. G.
    Neven, P.
    Barni, S.
    Gieseking, F.
    Nole, F.
    Pritchard, K. I.
    O'Malley, F. P.
    Simon, S. D.
    Kaufman, B.
    Petruzelka, L.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1246 - 1253
  • [32] Targeted Therapies in HER2-Overexpressing Metastatic Breast Cancer
    Labidi, Soumaya
    Mejri, Nesrine
    Lagha, Aymen
    Daoud, Nouha
    El Benna, Houda
    Afrit, Mehdi
    Boussen, Hamouda
    BREAST CARE, 2016, 11 (06) : 418 - 422
  • [33] Effects of trastuzumab and paclitaxel in HER2-overexpressing breast cancer
    Li, Songhua
    Higuchi, Hideo
    Ohuchi, Noriaki
    FUTURE MEDICAL ENGINEERING BASED ON BIONANOTECHNOLOGY, PROCEEDINGS, 2006, : 395 - +
  • [34] Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
    Malwina Stanowicka-Grada
    Elżbieta Senkus
    Current Treatment Options in Oncology, 2023, 24 : 1633 - 1650
  • [35] High incidence of brain metastases in HER2-overexpressing metastatic breast cancer (MBC) patients (pts) treated with trastuzumab and chemotherapy
    Gori, S.
    Rimondini, S.
    De Angelis, V.
    Sidoni, A.
    Mosconi, A. M.
    Aristei, C.
    Franceschi, E.
    Esposti, R. Degli
    Colozza, M.
    Crino, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 115 - 116
  • [36] Underutilization of anthracyclines in the management of HER2-overexpressing advanced breast cancer patients
    Montemurro, F.
    Redana, S.
    Valabrega, G.
    Donadio, M.
    Jacomuzzi, M. E.
    Vietti-Ramus, G.
    Clavarezza, M.
    Danese, S.
    Durando, A.
    Venturini, M.
    Aglietta, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI9 - XI10
  • [37] Immune microenvironment dynamics of HER2 overexpressing breast cancer under dual anti-HER2 blockade
    Batalha, Sofia
    Gomes, Catarina Monteiro
    Brito, Catarina
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] HER2-positive breast cancer, how far away from the cure?-on the current situation of anti-HER2 therapy in breast cancer treatment and survival of patients
    Liao, Ning
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (03)
  • [39] Treatment of brain metastases in patients with HER2+ breast cancer
    Bravo Marques J.M.
    Advances in Therapy, 2009, 26 (Suppl 1) : S18 - S26
  • [40] Anti-HER2 therapy for breast cancer in older patients
    Goldner, Marcelle
    Franzoi, Maria A.
    Lago, Lissandra D.
    Ponde, Noam
    FUTURE ONCOLOGY, 2020, 16 (19) : 1393 - 1407
12345